Literature DB >> 20607387

Effects of blood glutamate scavenging on cortical evoked potentials.

Dávid Nagy1, Levente Knapp, Máté Marosi, Tamás Farkas, Zsolt Kis, László Vécsei, Vivian I Teichberg, József Toldi.   

Abstract

It is well known that traumatic or ischemic brain injury is followed by acute excitotoxicity caused by the presence of abnormally high glutamate (Glu) in brain fluids. It has recently been demonstrated that excess Glu can be eliminated from brain into blood following the intravenous administration of oxaloacetate (OxAc), which, by scavenging blood Glu, induces an enhanced and neuroprotective brain-to-blood Glu efflux. In this study, we subjected rats to intravenous OxAc administration (i.v., 12.5, 25, and 50 mg/kg, respectively), and studied its effects on somatosensory evoked cortical potentials (EPs). Against our expectation, the amplitudes of EPs did not decrease but increased in a dose- and time-dependent manner after OxAc administration. Similar effects were observed when blood Glu scavenging was enhanced by combining OxAc (12.5 mg/kgbw) with recombinant glutamate-oxaloacetate transaminase (GOT, 0.14 nmol/100 g rat). On the basis of these results, we suggest that the changes of amplitudes of the EPs involve not only a glutamatergic but also the weakening of a GABAergic component. We cannot rule out the possibility that OxAc penetrates into the brain and improves mitochondrial functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607387     DOI: 10.1007/s10571-010-9542-8

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  30 in total

1.  Facial nerve injury-induced disinhibition in the primary motor cortices of both hemispheres.

Authors:  T Farkas; J Perge; Z Kis; J R Wolff; J Toldi
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

2.  Biphasic modulation of GABA release from stellate cells by glutamatergic receptor subtypes.

Authors:  Siqiong June Liu
Journal:  J Neurophysiol       Date:  2007-05-30       Impact factor: 2.714

Review 3.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

4.  Release of excitatory amino acids in the penumbra of a focal cortical necrosis.

Authors:  Michael Stoffel; Nikolaus Plesnila; Jörg Eriskat; Monika Fürst; Alexander Baethmann
Journal:  J Neurotrauma       Date:  2002-04       Impact factor: 5.269

5.  A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists.

Authors:  M Kessler; T Terramani; G Lynch; M Baudry
Journal:  J Neurochem       Date:  1989-04       Impact factor: 5.372

6.  Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus.

Authors:  Rasoul Farazifard; Shu Hui Wu
Journal:  Brain Res       Date:  2010-02-11       Impact factor: 3.252

Review 7.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 8.  Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies.

Authors:  V I Teichberg; K Cohen-Kashi-Malina; I Cooper; A Zlotnik
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

9.  Interaction of cortical evoked potentials in the rat.

Authors:  O Holmes; A D Short
Journal:  J Physiol       Date:  1970-08       Impact factor: 5.182

10.  Hydrogen peroxide modulation of synaptic plasticity.

Authors:  Ariel Kamsler; Menahem Segal
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

View more
  6 in total

1.  Amelioration of ischemic brain damage by peritoneal dialysis.

Authors:  María del Carmen Godino; Victor G Romera; José Antonio Sánchez-Tomero; Jesus Pacheco; Santiago Canals; Juan Lerma; José Vivancos; María Angeles Moro; Magdalena Torres; Ignacio Lizasoain; José Sánchez-Prieto
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?

Authors:  Robert Dantzer; Adam K Walker
Journal:  J Neural Transm (Vienna)       Date:  2014-03-15       Impact factor: 3.575

3.  Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.

Authors:  Evgeni Brotfain; Ruslan Kutz; Julia Grinshpun; Benjamin F Gruenbaum; Shaun E Gruenbaum; Amit Frenkel; Agzam Zhumadilov; Vladimir Zeldetz; Yoav Bichovsky; Matthew Boyko; Moti Klein; Alexander Zlotnik
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

4.  Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat.

Authors:  L Knapp; L Gellért; K Kocsis; Z Kis; T Farkas; L Vécsei; J Toldi
Journal:  Cell Mol Neurobiol       Date:  2014-05-08       Impact factor: 5.046

Review 5.  The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.

Authors:  Zsófia Majláth; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2013-12-18       Impact factor: 3.575

Review 6.  Glutamate as a neurotransmitter in the healthy brain.

Authors:  Y Zhou; N C Danbolt
Journal:  J Neural Transm (Vienna)       Date:  2014-03-01       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.